Literature DB >> 18408886

Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2.

L Todesco1, D Bur, H Brooks, M Török, L Landmann, B Stieger, S Krähenbühl.   

Abstract

The high-affinity Na+-dependent carnitine transporter OCTN2 (SLC22A5) has a high renal expression and reabsorbs most filtered carnitine. To gain more insight into substrate specificity of OCTN2, we overexpressed hOCTN2 in L6 cells and characterized the structural requirements of substances acting as human OCTN2 (hOCTN2) inhibitors. A 1905-bp fragment containing the hOCTN2 complete coding sequence was introduced into the pWpiresGFP vector, and L6 cells were stably transduced using a lentiviral system. The transduced L6 cells revealed increased expression of hOCTN2 on the mRNA, protein and functional levels. Structural requirements for hOCTN2 inhibition were predicted in silico and investigated in vitro. Essential structural requirements for OCTN2 inhibition include a constantly positively charged nitrogen atom and a carboxyl, nitrile or ester group connected by a 2-4-atom linker. Our cell system is suitable for studying in vitro interactions with OCTN2, which can subsequently be investigated in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408886     DOI: 10.1007/s00018-008-8065-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  7 in total

1.  Inhibition of OCTN2-mediated transport of carnitine by etoposide.

Authors:  Chaoxin Hu; Cynthia S Lancaster; Zhili Zuo; Shuiying Hu; Zhaoyuan Chen; Jeffrey E Rubnitz; Sharyn D Baker; Alex Sparreboom
Journal:  Mol Cancer Ther       Date:  2012-03-02       Impact factor: 6.261

2.  High affinity carnitine transporters from OCTN family in neural cells.

Authors:  Elzbieta Januszewicz; Marek Bekisz; Jerzy W Mozrzymas; Katarzyna A Nałecz
Journal:  Neurochem Res       Date:  2010-02-09       Impact factor: 3.996

3.  Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2010-09-29       Impact factor: 4.939

4.  A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis.

Authors:  Sean Ekins; Lei Diao; James E Polli
Journal:  Mol Pharm       Date:  2012-02-28       Impact factor: 4.939

5.  Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies.

Authors:  Sook Wah Yee; Dina Buitrago; Adrian Stecula; Huy X Ngo; Huan-Chieh Chien; Ling Zou; Megan L Koleske; Kathleen M Giacomini
Journal:  FASEB J       Date:  2020-10-30       Impact factor: 5.191

6.  Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testing.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Pharm Res       Date:  2009-05-13       Impact factor: 4.200

Review 7.  SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.

Authors:  Barbara Juraszek; Katarzyna A Nałęcz
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.